Company Overview of Aralez Pharmaceuticals Inc.
Seth A. Rudnick M.D.
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, Aralez Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 12 Board Members in 12 different organizations across 21 different industries.|
See Board Relationships
151 Steeles Avenue EastPhone: 905-876-1118
Milton, Ontario L9T 1Y1
Board Members Memberships
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Chairman of the Board
Chairman and Scientific and Clinical Advisor
University of Pennsylvania
University of Virginia
Washington University, St. Louis
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Paul V. Campanelli||Chief Executive Officer, President and Director|
Endo International plc
|Daniel N. Swisher Jr.||Chief Executive Officer, President and Director|
Sunesis Pharmaceuticals, Inc.
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co., Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|$3.2M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.